Exact Sciences

Exact Sciences

Exact Sciences

We manufacture Cologuard®, a noninvasive colon cancer screening test. Focused on the early detection and prevention of colorectal cancer.
Founded
1995
Follow us
Alexa global traffic share
Twitter followers
Team Size
500+
Employees
Xconomy

FDA Decision Expands Market for Exact Sciences’ Cologuard Test

Reuters Top News

Exact Sciences in advanced talks to buy Genomic Health for $2.8...

Xconomy

Exact Sciences Eyes Cologuard Market Expansion After "Landmark Year"

Xconomy

WI Watchlist: Northwestern Mutual, Epic, Exact Sciences, Propeller

Xconomy

Exact Sciences Seeks Up to $190M in Latest Stock Offering

Earnings
Xconomy

Exact Sciences Needs New Study to Fully Benefit From ACS Change

Health
Xconomy

Exact Sciences CEO Conroy Talks Growth, Foxconn, Startups & More

Health
Xconomy

COO Maneesh Arora Leaving Exact Sciences; More Earnings Call Tidbits

Earnings
Xconomy

Exact Sciences Beats Quarterly Forecasts, Sending Its Stock Price Up

Earnings Announcements
Xconomy

Baird: Exact Sciences Should Rebound After First-Quarter ‘Headwinds’

Earnings Announcements Health
Xconomy

Exact Sciences: Harry Connick Jr., Wife to Lead New Cancer Campaign

Health
Xconomy

Exact Sciences Shares Fall, Despite Better-Than-Expected P&L Results

Earnings Announcements
Xconomy

Exact Sciences, Generic Drugs, WEDC & More: This Week’s WI Watchlist

Health
Xconomy

Armune Bio’s Cancer Detection Tech Finds New Home with Exact Sciences

Health Science
Xconomy

Exact Sciences, Shine, Redox & More: This Week’s Wisconsin Watchlist

Health
Xconomy

Exact Sciences Plots Expansion Strategy as Cancer Test Sales Boom

Earnings
Xconomy

Exact Sciences Again Boosts Sales Projections for Flagship Product

Earnings Announcements
Xconomy

Exact Sciences To Sell 7 to 8 Million Shares in Stock Offering

Health
Xconomy

Shares in Exact Sciences Rise on UnitedHealthcare Coverage Decision

Health
Xconomy

Exact Sciences CEO Defends Company Against Short-Seller’s Criticism

Health